◆ TICKERBASE交互式视图 →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

首页 › 全部股票 › FTV · English version

Fortive Corp (FTV)

来自官方财务报表的收入、利润与现金流历史。

Industrials · 华尔街(美国) · 最近更新: 2026-11-04

Fortive Corporation 在美国、中国和国际上设计、开发、制造和销售产品、软件和服务。它通过智能运营解决方案和高级医疗解决方案部门运营。智能操作解决方案部门提供先进的仪器仪表、软件和服务,包括维护、维修、测量和状态监测、设施和资产生命周期软件应用程序,以及面向制造、流程工业、医疗保健、公用事业和电力、通信和电子以及其他行业的互联工人安全和合规解决方案。该部门以 ACCRUENT、FLUKE、GORDIAN、INDUSTRIAL SCIENTIFIC、INTELEX 和 SERVICECHANNEL 品牌销售其产品和服务。高级医疗保健解决方案部门提供关键的工作流程解决方案,包括仪器灭菌、仪器跟踪、生物医学测试工具、辐射检测和安全监测以及端到端临床生产力软件和解决方案,品牌名称包括 ASP、CENSIS、FLUKE BIOMEDICAL、LANDAUER 和 PROVATION。 Fortive Corporation 成立于 2015 年,总部位于华盛顿州埃弗里特。

机器翻译

关键数据

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表TTM → 2026-09-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
总收入$4.4B$5.1B$6.2B$6.1B$5.8B$5.3B$4.6B$4.6B$6.5B$5.8B$6.2B$6.2B$6.3B$6.0B$5.8B
毛利$2.8B$3.1B$3.7B$3.6B$3.4B$3.0B$2.6B$2.5B$3.3B$2.9B$3.0B$3.0B$3.1B$2.9B$2.8B
毛利率%63.5%61.0%59.9%59.3%57.7%57.3%56.5%54.7%51.5%50.8%48.9%48.6%48.2%48.2%48.1%
营业利润(EBIT)$864M$909M$1.2B$1.1B$1.0B$832M$650M$529M$1.2B$1.2B$1.3B$1.3B$1.3B$1.2B$1.2B
营业利润率%19.7%17.7%18.9%18.7%17.3%15.8%14.0%11.6%18.4%20.2%20.4%20.9%20.1%19.7%20.2%
净利$651M$579M$833M$866M$755M$608M$1.6B$739M$2.9B$1.0B$872M$864M$883M$831M$764M
净利润率 %14.8%11.3%13.4%14.3%13.0%11.6%34.8%16.2%45.2%18.1%14.0%14.0%13.9%13.9%13.2%
EBITDA—$1.2B$1.7B$1.1B$1.4B$1.2B$2.0B$821M$1.4B$1.3B$1.4B$1.4B$1.5B$1.3B$1.3B
每股收益(EPS)$2.10$1.81$2.36$2.43$2.09$1.73$4.49$2.17$8.31$2.96$2.51$2.50$2.56$2.41$2.21
已发行股数 (M)—319M353M356M361M352M359M340M351M353M347M345M345M345M345M

来源:公司公开报告(SEC)。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 FTV 交互式查看器。 /companies/us/FTV

类似公司

本网站信息仅用于教育与参考,不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.